We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Releases Draft Guidance on Threshold Analyses and Human Factors Submissions
FDA Releases Draft Guidance on Threshold Analyses and Human Factors Submissions
In new draft guidance issued Friday, the FDA outlined what it expects sponsors to include in submissions of use-related risk analyses, threshold analyses, comparative use human factors (HF) and HF validation study protocols and reports.